The possible reason may be that GSTM1 null genotype could influence the susceptibility to non-cancer diseases, such as COPD [84], alcoholic liver disease [85], and coronary heart disease [86], so its genotype frequency possibly differed between the hospital-based and population-based controls. The gene discussed is GSTM1; the disease is alcoholic liver diseases.